Clinical Trial Update: Continuous Subcutaneous Infusion of Pramlintide and Insulin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating continuous subcutaneous infusion of pramlintide with insulin in Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Symlin (pramlintide)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED